Order Article Reprints

Di Scala C, Armstrong N, Chahinian H, Chabrière E, Fantini J, Yahi N. AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer’s and Parkinson’s Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery. International Journal of Molecular Sciences. 2022; 23(21):13383. https://doi.org/10.3390/ijms232113383

Di Scala, Coralie, Nicholas Armstrong, Henri Chahinian, Eric Chabrière, Jacques Fantini, and Nouara Yahi. 2022. "AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer’s and Parkinson’s Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery" International Journal of Molecular Sciences 23, no. 21: 13383. https://doi.org/10.3390/ijms232113383

Di Scala, C., Armstrong, N., Chahinian, H., Chabrière, E., Fantini, J., & Yahi, N. (2022). AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer’s and Parkinson’s Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery. International Journal of Molecular Sciences, 23(21), 13383. https://doi.org/10.3390/ijms232113383